Keytruda hits endpoints in triple-negative breast cancer by Anna Smith | Feb 13, 2020 | News | 0 Earlier this week, NICE released a draft guidance rejecting Keytruda when used in combo with Pfizer’s Inlyta (axitinib) to treat advanced renal cell carcinoma. Read More
US OKs first-line use of Novartis’ Zykadia in lung cancer by Selina McKee | May 30, 2017 | News | 0 US regulators have green-lighted the use of Novartis Zykadia as a first-line treatment option for some patients with non-small cell lung cancer. Read More